These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 20708851)

  • 1. Cognitive functioning after radiotherapy or chemoradiotherapy for head-and-neck cancer.
    Gan HK; Bernstein LJ; Brown J; Ringash J; Vakilha M; Wang L; Goldstein D; Kim J; Hope A; O'Sullivan B; Waldron J; Abdul Razak AR; Chen EX; Siu LL
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):126-34. PubMed ID: 20708851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant adjuvant chemoradiotherapy with weekly low-dose cisplatin for high-risk squamous cell carcinoma of the head and neck: a phase II prospective trial.
    Rampino M; Ricardi U; Munoz F; Reali A; Barone C; Musu AR; Balcet V; Franco P; Grillo R; Bustreo S; Pecorari G; Cavalot A; Garzino Demo P; Ciuffreda L; Ragona R; Schena M
    Clin Oncol (R Coll Radiol); 2011 Mar; 23(2):134-40. PubMed ID: 21030225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Taxan induction chemotherapy and concomitant chemoradiotherapy with cisplatin in patients with locally advanced head and neck cancer--early results].
    Chilimoniuk M; Olszewska E; Maksimowicz T
    Pol Merkur Lekarski; 2010 Dec; 29(174):357-60. PubMed ID: 21298984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant weekly cisplatin and radiotherapy for head and neck cancer.
    Homma A; Inamura N; Oridate N; Suzuki S; Hatakeyama H; Mizumachi T; Kano S; Sakashita T; Onimaru R; Yasuda K; Shirato H; Fukuda S
    Jpn J Clin Oncol; 2011 Aug; 41(8):980-6. PubMed ID: 21715362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I/II study of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck.
    Herchenhorn D; Dias FL; Viegas CM; Federico MH; Araújo CM; Small I; Bezerra M; Fontão K; Knust RE; Ferreira CG; Martins RG
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):696-702. PubMed ID: 20421154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synchronous chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck using capecitabine: a single-centre, open-label, single-group phase II study.
    Jegannathen A; Mais K; Sykes A; Lee L; Yap B; Birzgalis A; Homer J; Ryder WD; Slevin N
    Clin Oncol (R Coll Radiol); 2011 Mar; 23(2):149-58. PubMed ID: 20951012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma.
    Dirix P; Nuyts S
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1373-80. PubMed ID: 20362402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck.
    Lang K; Sussman M; Friedman M; Su J; Kan HJ; Mauro D; Tafesse E; Menzin J
    Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):582-8. PubMed ID: 19528407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of interim FDG-PET after induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck receiving sequential induction chemotherapy followed by concurrent chemoradiotherapy.
    Yoon DH; Cho Y; Kim SY; Nam SY; Choi SH; Roh JL; Lee SW; Song SY; Lee JH; Kim JS; Cho KJ; Kim SB
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):118-25. PubMed ID: 20675065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of postoperative simultaneous modulated accelerated radiotherapy for head-and-neck squamous cell carcinoma.
    Moon SH; Jung YS; Ryu JS; Choi SW; Park JY; Yun T; Lee SH; Cho KH
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):140-9. PubMed ID: 20732767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid dysfunction after intra-arterial chemotherapy for hypopharyngeal and laryngeal cancer.
    Endo K; Masatani T; Tsuji A; Kondo S; Wakisaka N; Murono S; Yoshizaki T
    Auris Nasus Larynx; 2015 Jun; 42(3):231-4. PubMed ID: 25544714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of four cisplatin-based radiochemotherapy regimens for nonmetastatic stage III/IV squamous cell carcinoma of the head and neck.
    Rades D; Kronemann S; Meyners T; Bohlen G; Tribius S; Kazic N; Schroeder U; Hakim SG; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1037-44. PubMed ID: 20638185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity of cetuximab versus cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer (LAHNSCC).
    Walsh L; Gillham C; Dunne M; Fraser I; Hollywood D; Armstrong J; Thirion P
    Radiother Oncol; 2011 Jan; 98(1):38-41. PubMed ID: 21159400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction chemotherapy in head and neck cancer patients followed by concomitant docetaxel-based radiochemotherapy.
    Mencoboni M; Grillo-Ruggieri F; Salami A; Scasso F; Rebella L; Grimaldi A; Dellepiane M; Moratti G; Bruzzone A; Spigno F; Ghio R; Figliomeni M
    Eur J Cancer Care (Engl); 2011 Jul; 20(4):503-7. PubMed ID: 20477856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
    Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
    Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
    Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective assessment of patterns of failure after high-precision definitive (chemo)radiation in head-and-neck squamous cell carcinoma.
    Gupta T; Jain S; Agarwal JP; Ghosh-Laskar S; Phurailatpam R; Pai-Shetty R; Dinshaw KA
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):522-31. PubMed ID: 20646862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures.
    Dirix P; Abbeel S; Vanstraelen B; Hermans R; Nuyts S
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):385-92. PubMed ID: 19553033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RapidArc planning and delivery in patients with locally advanced head-and-neck cancer undergoing chemoradiotherapy.
    Doornaert P; Verbakel WF; Bieker M; Slotman BJ; Senan S
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):429-35. PubMed ID: 20421159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enteral feeding during chemoradiotherapy for advanced head-and-neck cancer: a single-institution experience using a reactive approach.
    Clavel S; Fortin B; Després P; Donath D; Soulières D; Khaouam N; Charpentier D; Bélair M; Guertin L; Nguyen-Tan PF
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):763-9. PubMed ID: 20510546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.